Thromb Haemost 2000; 84(03): 410-412
DOI: 10.1055/s-0037-1614036
Commentary
Schattauer GmbH

A Comparison of INRs Determined with a Whole Blood Prothrombin Time Device and two International Reference Preparations for Thromboplastin

A. M. H. P. van den Besselar
1   From the Haemostasis and Thrombosis Research Centre, Leiden University Medical Centre, Leiden, The Netherlands
› Author Affiliations
Excellent technical assistance was provided by J. Meeuwisse-Braun, C. van Rijn, H. Schaefer-van Mansfeld, and E. Witteveen. The staff of the Leiden Thrombosis Service assisted in the recruitment of patients on long-term oral anticoagulant therapy. Roche Diagnostics provided the CoaguChek PT system and financial support to perform this study. International reference preparations for thromboplastin were provided by the WHO laboratory at Amsterdam, The Netherlands. The critical reading of the draft manuscript by Dr. W. Plesch is greatly appreciated.
Further Information

Publication History

Received 24 November 1999

Accepted after resubmission 17 April 2000

Publication Date:
14 December 2017 (online)

Summary

Oral anticoagulant therapy is usually monitored with the prothrombin time (PT) on citrate plasma samples. In recent years instruments have been developed for measurement of the PT in non-citrated whole blood. In the present study, the manufacturer’s calibration of one type of device (CoaguChek®) in terms of the international normalized ratio (INR) was evaluated by one laboratory. Three subsequent lots of test strips for the CoaguChek were investigated using blood samples from 56 coumarin-treated patients. Citrated plasma samples from the same patients were analysed with two international reference preparations for thromboplastin (IRP), i. e., rTF/95 (recombinant human) and RBT/90 (rabbit brain). There were statistically significant INR differences between CoaguChek and the international reference preparations (p <0.001), but the mean relative deviation of the INR was not greater than 0.104. Clinically relevant criteria were used to assess the agreement between the CoaguChek and the IRP results. Standard agreement ranged from 82% to 95%. It is concluded that these test strips achieved a clinically acceptable level of accuracy. Further studies of patient management with these strips are justified.

 
  • References

  • 1 Poggio M, Van den Besselaar AMHP, Van der Velde EA, Bertina RM. The effect of some instruments for prothrombin time testing on the international sensitivity index (ISI) of two rabbit tissue thromboplastin reagents. Thromb Haemost 1989; 62: 868-74.
  • 2 Kaatz SS, White RH, Hill J, Mascha E, Humphries JE, Becker DM. Accuracy of laboratory and portable monitor international normalized ratio determinations. Comparison with a criterion standard. Arch Intern Med 1995; 155: 1861-7.
  • 3 Kirkwood TBL. Calibration of reference thromboplastins and standardisation of the prothrombin time ratio. Thromb Haemost 1983; 49: 238-44.
  • 4 Bland JM, Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 1995; 346: 1085-7.
  • 5 Hill J. Determination of INR accuracy: methods of analysis. Haemostasis. 1996 26. (suppl 3): abstract 422.
  • 6 Anderson DR, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Intern Med 1993; 153: 1441-7.
  • 7 Douketis JD, Lane A, Milne J, Ginsberg JS. Accuracy of a portable international normalized ratio monitor in outpatients receiving long-term oral anticoagulant therapy: comparison with a laboratory reference standard using clinically relevant criteria for agreement. Thromb Res 1998; 92: 11-7.
  • 8 Hill J, Plesch W. Evaluation of CoaguChek INR results from venous whole blood versus capillary whole blood. Thromb Haemost. 1997 (Suppl); abstract 3130.
  • 9 Quien ET, Morales E, Cisar LA, Kim HC, Cimini C, Saidi P, Philipp CS. Plasma tissue factor antigen levels in capillary whole blood and venous blood: effect of tissue factor on prothrombin time. Am J Hematol 1997; 55: 193-8.
  • 10 Van den Besselaar AMHP. Multi-center study of replacement of the international reference preparation for thromboplastin, rabbit, plain. Thromb Haemost 1993; 70: 794-9.
  • 11 Van den Besselaar AMHP, Bertina RM, Van der Meer FLM, Den Hartigh J. Different sensitivities of various thromboplastins to two blood collection systems for monitoring oral anticoagulant therapy. Thromb Haemost 1999; 82: 153-4.
  • 12 Tripodi A, Chantarangkul V, Negri B, Clerici M, Mannucci PM. International collaborative study for the calibration of a proposed reference preparation for thromboplastin, human recombinant, plain. Thromb Haemost 1998; 79: 439-43.
  • 13 Poller L, Van den Besselaar AMHP, Jespersen J, Tripodi A, Houghton D. The effect of sample size on fresh plasma thromboplastin ISI determination. Br J Haematol 1999; 105: 655-63.
  • 14 Van den Besselaar AMHP, Breddin K, Lutze G, Parker-Williams J, Taborski U, Vogel G, Tritschler W, Zerback R, Leinberger R. Multicenter evaluation of a new capillary blood prothrombin time monitoring system. Blood Coag Fibrinolysis 1995; 06: 726-32.
  • 15 Attermann J, Kynde K, Hasenkam JM. Precision of patients’ measurements of the international normalized ratio (INR) using a patient operated whole blood home coagulometer. Thromb Res 1998; 92: 287-91.